Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Abrams

Showing results (311-320 of 367) with videos related to

Pageof 37
Sort By:
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
Aging|February 5, 2020
New landscapes and horizons in hepatocellular carcinoma therapyMelchiorre Cervello, Maria R Emma, Giuseppa Augello, et al.
Transplantation Direct|March 20, 2023
An Initial Analysis of the Baseline Levels of Dd-cfDNA After Pancreas Transplantation: A Prospective Study From High-volume Centers in the United StatesAshley Yoo, Alexandria Riedel, Ian Qian, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
Advances in Biological Regulation|October 26, 2016
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisJames A McCubrey, Kvin Lertpiriyapong, Timothy L Fitzgerald, et al.
Advances in Biological Regulation|October 6, 2020
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signalingLinda S Steelman, William H Chappell, Shaw M Akula, et al.
Veterinary Ophthalmology|June 23, 2015
Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapyAndrás M Komáromy, Kenneth L Abrams, John R Heckenlively, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.
Cells|May 6, 2020
Targeting GSK3 and Associated Signaling Pathways Involved in CancerPrzemysław Duda, Shaw M Akula, Stephen L Abrams, et al.
Pageof 37

Showing results (311-320 of 367) with videos related to

Sort By:
Pageof 37
Advances in Biological Regulation|January 16, 2021
Sensitivity of pancreatic cancer cells to chemotherapeutic drugs, signal transduction inhibitors and nutraceuticals can be regulated by WT-TP53Stephen L Abrams, Shaw M Akula, Alberto M Martelli, et al.
Aging|February 5, 2020
New landscapes and horizons in hepatocellular carcinoma therapyMelchiorre Cervello, Maria R Emma, Giuseppa Augello, et al.
Transplantation Direct|March 20, 2023
An Initial Analysis of the Baseline Levels of Dd-cfDNA After Pancreas Transplantation: A Prospective Study From High-volume Centers in the United StatesAshley Yoo, Alexandria Riedel, Ian Qian, et al.
Aging|June 4, 2020
Influences of TP53 and the anti-aging DDR1 receptor in controlling Raf/MEK/ERK and PI3K/Akt expression and chemotherapeutic drug sensitivity in prostate cancer cell linesWilliam H Chappell, Saverio Candido, Stephen L Abrams, et al.
Advances in Biological Regulation|October 26, 2016
Roles of TP53 in determining therapeutic sensitivity, growth, cellular senescence, invasion and metastasisJames A McCubrey, Kvin Lertpiriyapong, Timothy L Fitzgerald, et al.
Advances in Biological Regulation|October 6, 2020
Therapeutic resistance in breast cancer cells can result from deregulated EGFR signalingLinda S Steelman, William H Chappell, Shaw M Akula, et al.
Veterinary Ophthalmology|June 23, 2015
Sudden acquired retinal degeneration syndrome (SARDS) - a review and proposed strategies toward a better understanding of pathogenesis, early diagnosis, and therapyAndrás M Komáromy, Kenneth L Abrams, John R Heckenlively, et al.
Cell Cycle (Georgetown, Tex.)|May 4, 2010
The Raf/MEK/ERK pathway can govern drug resistance, apoptosis and sensitivity to targeted therapyStephen L Abrams, Linda S Steelman, John G Shelton, et al.
Leukemia|March 14, 2008
Targeting survival cascades induced by activation of Ras/Raf/MEK/ERK, PI3K/PTEN/Akt/mTOR and Jak/STAT pathways for effective leukemia therapyJ A McCubrey, L S Steelman, S L Abrams, et al.
Cells|May 6, 2020
Targeting GSK3 and Associated Signaling Pathways Involved in CancerPrzemysław Duda, Shaw M Akula, Stephen L Abrams, et al.
Pageof 37